Bio-Techne (TECH) Leases (2019 - 2026)

Bio-Techne has reported Leases for 8 years, with the latest figure at $68.3 million in Q1 2026.

• For the quarter ending Q1 2026, Leases fell 18.42% year-over-year to $68.3 million; the trailing twelve-month figure through Mar 2026 stood at $68.3 million (down 18.42% YoY), and the FY2025 full-year result was $73.4 million, down 19.59% from the prior year.
• Leases for Q1 2026 stood at $68.3 million, roughly flat from $68.2 million in the prior quarter.
• The five-year high for Leases was $102.3 million in Q3 2023, with the low at $63.4 million in Q1 2022.
• Average Leases over 5 years is $82.9 million, with a median of $83.9 million recorded in 2022.
• Year-over-year, Leases jumped 54.41% in 2023 and slipped 20.73% in 2025.
• Tracing TECH's Leases over 5 years: stood at $83.9 million in 2022, then advanced by 20.17% to $100.9 million in 2023, then fell by 15.35% to $85.4 million in 2024, then retreated by 20.07% to $68.2 million in 2025, then rose by 0.1% to $68.3 million in 2026.
• The last three Leases figures came in at $68.3 million (Q1 2026), $68.2 million (Q4 2025), and $70.7 million (Q3 2025), per Business Quant data.

Peer Comparison